Posted by SLS on December 14, 2006, at 14:06:57
In reply to New Drug Development-Seranductant?, posted by Tom Twilight on December 14, 2006, at 11:43:58
> I'm not sure about 5HT1A Agonists-I think they might not be all there hyped up to be
> Hopefully I'm wrong :)By themselves, perhaps not. However, they might make good augmentors - sort of like Buspar without the dopamine receptor blockade. Also, the metabolite (1-PP) of gepirone acts like Remeron in that it is a NE alpha-2 receptor antagonist. I don't care under what pretenses it becomes available. It would be one more tool to work with.
- Scott
poster:SLS
thread:713473
URL: http://www.dr-bob.org/babble/20061212/msgs/713637.html